1. Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma 
Narendranath Epperla, Kwang Woo Ahn, Philippe Armand, Samantha Jaglowski, Sairah Ahmed, Vaishalee P. Kenkre, Bipin Savani, Madan Jagasia, Nirav N. Shah, Timothy S. Fenske, Anna Sureda, Sonali M. Smith, Mehdi Hamadani 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 1, Pages (January 2018)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Adjusted cumulative incidence of chronic GVHD for patients receiving Flu/Bu (dashed line) and FCR (solid line) regimens.
Biology of Blood and Marrow Transplantation  , 78-85DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Adjusted transplantation outcomes of patients receiving Flu/Bu (dashed line) and FCR (solid line) regimens. (A) Cumulative incidence of relapse. (B) Cumulative incidence of NRM. (C) Cumulative incidence of PFS. (D) Cumulative incidence of OS.
Biology of Blood and Marrow Transplantation  , 78-85DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions